dr nirmal latest biodata - punjabi university&kdxkdq ( %dol $ 6lqjk 1 -djjl $6 &urvv vwuhvv...

$: Dr Nirmal latest biodata - Punjabi University&kdxkdq ( %dol $ 6lqjk 1 -djjl $6 &urvv vwuhvv dgdswdwlrq 3khqrphqrq ri lqwhudfwlrqv ehwzhhq krprw\slf dqg khwhurw\slf vwuhvvruv /lih 6fl$
BIO-DATA

1. Name : Dr Nirmal Singh

2. Designation : Professor

3. Department : Pharm. Sci. & drug Research

4. Date of Birth : 01-04-1968

5. Address for

Correspondence

: Deptt Pharmaceutical Sciences

& Drug Research, Punjabi

University,

Patiala.

PIN: 147002

Phones : 91-175-3046254

Mobile : 91-9815129884

Fax :0175-2283073

E-mail :[email protected]

6 Areas of

Specialisation

: Memory and dementia, Alzheimer’s disease, drug withdrawal syndrome,

Cerebral ischemia/reperfusion injury, Neuropathy

7. Academic Qualifications:

Sr. no.

Degree Held

Year Board/Univ./ Inst.

% of Marks

Div./ Rank

Subjects Taken

1 B.Pharm 1992 Gulbarga University, Karnataka. India

73% Dist’n Pharmaceutics, Pharmacology Pharm. Chem, Pharmacognosy etc.

2 M.Pharm (Pharmacology)

1997 Punjabi University, Patiala, india

62% First Pharmacology

3 Ph.D 2008 G.J.U.Hisar, Haryana, India

Animal Models of memory

8. Membership of Professional Bodies/Organisations

Life member, Indian Pharmacological Society. Life member Association of Pharmacy Teachers in India Life member Punjab science congress Elected member of Executive Committee of Indian Pharmacological Society 2012.

9. Details of Experience:

S. No.

Name of the Inst./Employer

Position Held

Duration Major Job Responsibilities and Nature of Experience

1. Kim Labs Pvt Ltd, Ambala Cantt India

Asst Production Chemist

1 years Batch Handling and Documentation in Tablet, Capsule, Liquid Oral and Dry Syrup manufacturing sections

2. Unisule Pvt Ltd, Sonepat India

Production Executive

2.5 years Shift In charge, manufacturing and Documentation Tablet, Capsule and Dry Syrup sections.

3. Hindu College of Pharmacy, Sonepat, India

Lecturer 4.2 years Teaching. Subject Taught: Pharmacology and Physiology.

4. Deptt of Pharma Sci & Drug Research, Punjabi University, Patiala

Lecturer, Sr. Lecturer, Associate Professor, Professor

14 years Still continuing

Teaching and Research. Subject teaching: Pharmacology.

10. Published Work Research & Review articles in National & International Journal: 171 Books: 04 Book Chapters: 02 Abstracts: over 90

11. R & D Projects

MAJOR PROJECTS

S. No. Funding Agency Title Grant (Rs) Status

01 CSIR, New Delhi (Scheme No. 01/ (2344)/2009

Investigation on Potential of Acorus calamus plant extract in experimentally induced neuropathy (Principal Investigator)

10,30,000/- Completed

02 UGC, New Delhi [F. No. 39-160/2010 (SR)] 2010

Exploring neuroprotective mechanism of ischemic postconditioning in mice (Principal Investigator)


03 UGC, New Delhi Exploring the mechanisms in central sensitization in chronic-constriction-induced neuropathic pain in rats. (Co-investigator)


04 DST, New Delhi Exploring molecular mechanism of remote preconditioning-induced cardioprotection in ischemia-reperfusion-induced injury in rats (Co-investigator)

45,00,000/- In progress

12. Invited Talks / Reviewer / Expert

Invited Talks / Reviewer / Expert

Invited Talks:

Delivered over 35 invited talks as resource person in various National, International conferences, workshops, seminars, orientation and refresher courses

Reviewer:

Invited to function as a reviewer for “PLOS ONE” Invited to function as a reviewer for “Molecular and cellular biochemistry”. Springer Invited to function as a reviewer for “Psychopharmacology”. Springer Invited to function as a reviewer for “Alzheimer’s & Dementia”. Elsevier Invited to function as a reviewer for “Recent Patents in CNS Drug Discovery”. Bentham Science Publishers Invited to function as a reviewer for “Behaviour Brain research”. Elsevier Invited to function as reviewer for “Brain research”. Elsevier Invited to function as a reviewer for “Rejuvenation Research”. Mary Ann Liebert, Inc. Publishers Invited to function as a reviewer for “Pharmacological Research”. Elsevier Invited to function as a reviewer for “CNS Neuroscience and Therapeutics” Invited to function as a reviewer for “Pharmacology Biochemistry Behaviour”. Elsevier Invited to function as a reviewer for “Evidenced Based Complimentary and Alternative Medicines”. Oxford Journals Invited to function as a reviewer for “Journal of Alzheimer Disease”. IOS Press Invited to function as a reviewer for “Pharmaceutical Biology”. Invited to function as a reviewer for “Indian Journal of Pharmacology”. Medknow Publications

Expert:

Member expert of committee for the purpose of control and supervision of experiments on animals (CPCSEA), Chitkara College of Pharmacy, Ramnagar Banaur, Patiala.

CPCSEA socially aware nominee of Institutional animal ethics committee of NIPER Mohali

Member expert of committee for the purpose of control and supervision of experiments on animals (CPCSEA), Govt Women Polytechnic College, Patiala.

Member expert of committee for the purpose of control and supervision of experiments on animals (CPCSEA), Swami Vivekanand College of Pharmacy, SVIET, Ramnagar Banaur, Patiala.

Biodata entered in Marquis Who's Who in Engineering and Technology (2008-09; 2011-12; 2015-16)

13. M.Pharm Students guided: 60 (completed) + 05 (pursuing) 14. PhD Students guided: 07 (completed) + 03 (pursuing)

S. No. Name of the Student

Title of Thesis Year of Completion

1. Mr. Amteshwar Singh Jaggi

Exploring Novel Pharmacological Interventions for Experimental Peripheral Neuropathy

2012

2. Mr. Bhupesh Sharma Studies involving novel pharmacological interventions in experimentally induced vascular dementia

2012

3. Mr. Ashish K Rehni Exploring novel pharmacological approaches to attenuate experimental opioid dependence induced withdrawal syndrome in mice

2012

4. Mr. Muthuraman A Investigations on Ameliorative Effect of Acrous calamus in Experimentally Induced Peripheral Neuropathy

2012

5. Rupinder Kaur Sodhi Pharmacological Exploration of Selected Nuclear Receptors as Novel Target for Their Potential in Experimental Dementia

2013

6. Puja Gulati Investigations on Molecular Mechanisms of Neuroprotective Effect of Ischemic Postconditioning in Mice

2014

7. Vivek Jain Investigations on the Potential of Momordica charantia L and Punica granatum L in Rat Model of Neuropathic Pain.

2016

8. Amit Kumar Exploring Novel Pharmacological Targets to Attenuate Memory Deficits Associated with Dementia of Alzheimer’s Type

Pursuing

9. Kamaldeep Kaur Studies on novel targets in postconditioning to attenuate ischemia-reperfusion-induced myocardial injury.

Pursuing

10. Pankaj Bhatia Pharmacological exploration of selected phosphodiesterases and prostanoid receptros as potential targets in vascular dementia

Pursuing

15. List of Papers/Courses taught at P.G. and U.G. Level

S. No. Paper Class 1. APHE B. Pharm 1st 2. Pharmacology B. Pharm 3rd

3. Clinical Pharmacology B. Pharm. 4th 4. Toxicology and community pharmacy B. Pharm 4th 5. Forensic Pharmacy B. Pharm. 3rd

6. Clinical Pharmacol and Drug Therapy M. Pharm 1st 7. Drug Evaluation and advanced pharmacological techniques M. Pharm. 1st

8. Recent advances in pharmacology M. Pharm 2nd 9. Pharmacology Laboratory B. Pharm. &

M. Pharm

16. Technical Proficiency

Over the time, have acquired good industrial, teaching and research experience. Presently working on animal models of memory, Alzheimer’s disease, cerebral ischaemia reperfusion injury, neuropathy and vascular dementia.

17. Patents: 02

1. Shah DI, Kaur G, Singh S, Java PR, Bansal G, Singh N, Chopra D, Singh M. Formulation and evaluation of brain permeable statin loaded nanoparticles. WTO Indian Patent No.266818; 86/DEL/2007.

2. Shah DI, Kaur G, Chaudhary A, Java PR, Bansal G, Singh N, Chopra D, Singh M. Formulation and evaluation of brain permeable rosiglatazone loaded nanoparticles. WTO Indian Patent No. 266815; 87/DEL/2007

18. LIST OF PUBLICATIONS Research / Review Articles

1. Singh AP, Singh N, Bedi PMS. Estradiol mitigates ischemia reperfusion-induced acute renal

failure through NMDA receptor antagonism in rats. Mol Cell Biochem. 2017; doi: 10.1007/s11010-017-3034-9. [Epub ahead of print].

2. Aggarwal S, Randhawa PK, Singh N, Jaggi AS. Role of ATP-Sensitive Potassium Channels in Remote Ischemic Preconditioning Induced Tissue Protection. J Cardiovasc Pharmacol Ther. 2017 ; 22(5): 467-475.

3. Khangura RK, Bali A, Kaur G, Singh N, Jaggi AS. Neuropathic pain attenuating effects of perampanel in an experimental model of chronic constriction injury in rats. Biomed Pharmacother. 2017; 94: 557-563.

4. Kaur G, Singh N, Jaggi AS. Mast cells in neuropathic pain: an increasing spectrum of their involvement in pathophysiology. Rev Neurosci. 2017; 28(7): 759-766.

5. Singh AP, Singh N, Bedi PMS. Estradiol mitigates ischemia reperfusion-induced acute renal failure through NMDA receptor antagonism in rats. Mol Cell Biochem. 2017. doi: 10.1007/s11010-017-3034-9. [Epub ahead of print]

6. Singh L, Randhawa PK, Singh N, Jaggi AS. Redox signaling in remote ischemic preconditioning-induced cardioprotection: Evidences and mechanisms. Eur J Pharmacol. 2017; 809: 151-155

7. Jaggi AS, Kaur G, Bali A, Singh N. Pharmacological investigations on mast cell stabilizer and histamine receptor antagonists in vincristine-induced neuropathic pain. Naunyn Schmiedebergs Arch Pharmacol. 2017 Sep 15. doi: 10.1007/s00210-017-1426-8.

8. Aulakh AS, Randhawa PK, Singh N, Jaggi AS. Neurogenic pathways in remote ischemic preconditioning induced cardioprotection: Evidences and possible mechanisms. Korean J Physiol Pharmacol. 2017;21(2):145-152. doi: 10.4196/kjpp.2017.21.2.145.

9. Singh A, Randhawa PK, Bali A, Singh N, Jaggi AS. Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats. Cardiovasc Drugs Ther. 2017; doi: 10.1007/s10557-017-6716-3. [Epub ahead of print].

10. Kumar A, Singh N. Pharmacological activation of protein kinase A improves memory loss and neuropathological changes in a mouse model of dementia of Alzheimer's type. Behav Pharmacol. 2017; 28(2 and 3 - Special Issue):187-198.

11. Kaur I, Kumar A, Jaggi AS, Singh N. Evidence for the role of histaminergic pathways in neuroprotective mechanism of ischemic postconditioning in mice. Fundam Clin Pharmacol. 2017, doi: 10.1111/fcp.12275. [Epub ahead of print]

12. Kumar A, Singh N. Inhibitor of Phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer's Type. Biomed Pharmacother. 2017; 88:698-707..

13. Kumar A, Singh N. Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia. Pharmacol Biochem Behav. 2017; 153:147-159.

14. Khangura RK, Bali A, Jaggi AS, Singh N. Histone acetylation and histone deacetylation in neuropathic pain: An unresolved puzzle? Eur J Pharmacol. 2017;795:36-42.

15. Singh V, Krishan P, Singh N, Kumar A, Shri R. Amelioration of ischemia-reperfusion induced functional and biochemical deficit in mice by Ocimum kilimandscharicum leaf extract. Biomed Pharmacother. 2017;85:556-563.

16. Singh B, Randhawa PK, Singh N, Jaggi AS. Investigations on the role of leukotrienes in remote hind limb preconditioning-induced cardioprotection in rats. Life Sci. 2016; 152:238-43

17. Aggarwal S, Randhawa PK, Singh N, Jaggi AS. Preconditioning at a distance: Involvement of

endothelial vasoactive substances in cardioprotection against ischemia-reperfusion injury. Life Sci.

2016; 151:250-8.

18. Shah R, Singh J, Singh D, Jaggi AS, Singh N. Sulfatase inhibitors for recidivist breast cancer

treatment: A chemical review. Eur J Med Chem. 2016; 23; 114:170-90.

19. Verma M, Bali A, Singh N, Jaggi AS. Investigating the role of nisoldipine in foot-shock-induced

post-traumatic stress disorder in mice. Fundam Clin Pharmacol. 2016; 30(2):128-36.

20. Singh AP, Singh N, Singh Bedi PM. Estrogen attenuates renal IRI through PPAR-γ agonism in

rats. J Surg Res. 2016 Jun 15; 203(2):324-30.

21. Singh AP, Singh N, Bedi PM. Pioglitazone ameliorates renal ischemia reperfusion injury through

NMDA receptor antagonism in rats. Mol Cell Biochem. 2016 Jun; 417(1-2):111-8.

22. Sharma R, Randhawa PK, Singh N, Jaggi AS. Possible role of thromboxane A2 in remote hind

limb preconditioning-induced cardioprotection. Naunyn Schmiedebergs Arch Pharmacol. 2016;

389(1):1-9.

23. Sharma R, Randhawa PK, Singh N, Jaggi AS. Bradykinin in ischemic conditioning-induced tissue

protection: Evidences and possible mechanisms. Eur J Pharmacol. 2015; 768:58-70.

24. Jaggi AS, Kaur A, Bali A, Singh N. Expanding Spectrum of Sodium Potassium Chloride Co-

transporters in the Pathophysiology of Diseases. Curr Neuropharmacol. 2015; 13(3):369-88.

25. Bhatia P, Singh N. Homocysteine excess: delineating the possible mechanism of neurotoxicity

and depression. Fundam Clin Pharmacol. 2015; 29(6):522-8.

26. Chauhan E, Bali A, Singh N, Jaggi AS. Cross stress adaptation: Phenomenon of interactions

between homotypic and heterotypic stressors. Life Sci. 2015; 137:98-104.

27. Verma V, Bali A, Singh N, Jaggi AS. Implications of sodium hydrogen exchangers in various

brain diseases. Basic Clin Physiol Pharmacol. 2015; 26(5):417-26.

28. Kumar A, Kumar A, Jaggi AS, Singh N. Efficacy of Cilostazol a selective phosphodiesterase-3

inhibitor in rat model of Streptozotocin diabetes induced vascular dementia. Pharmacol Biochem

Behav. 2015; 135:20-30.

29. Kaur H, Kumar A, Jaggi AS, Singh N. Pharmacologic investigations on the role of Sirt-1 in

neuroprotective mechanism of postconditioning in mice. Surg Res. 2015; 197(1):191-200.

30. Mahi N, Kumar A, Jaggi AS, Singh N, Dhawan R. Possible role of pannexin 1/P2x7 purinoceptor

in neuroprotective mechanism of ischemic postconditioning in mice. Surg Res. 2015; 196(1):190-

9.

31. Chauhan E, Bali A, Singh N, Jaggi AS. Pharmacological investigations on cross adaptation in

mice subjected to stress immobilization. Life Sci. 2015; 127:98-105.

32. Bhalla S, Singh N, Jaggi AS. Dose-related neuropathic and anti-neuropathic effects of simvastatin

in vincristine-induced neuropathic pain in rats. Food Chem Toxicol. 2015; 80:32-40.

33. Kaur G, Bali A, Singh N, Jaggi AS. Ameliorative potential of Ocimum sanctum in chronic

constriction injury-induced neuropathic pain in rats. An Acad Bras Cienc. 2015; 87(1):417-29.

34. Kaur A, Bali A, Singh N, Jaggi AS. Investigating the stress attenuating potential of furosemide in

immobilization and electric foot-shock stress models in mice. Naunyn Schmiedebergs Arch

Pharmacol. 2015; 388(5):497-507.

35. Kumar A, Jaggi AS, Singh N. Pharmacology of Src family kinases and therapeutic implications of

their modulators. Fundam Clin Pharmacol. 2015; 29(2):115-30.

36. Bali A, Singh N, Jaggi AS. Renin-angiotensin system in pain: existing in a double life? Renin

Angiotensin Aldosterone Syst. 2014; 15(4):329-40.

37. Gulati P, Singh N. Pharmacological evidence for connection of nitric oxide-mediated pathways in

neuroprotective mechanism of ischemic postconditioning in mice. Pharm Bioallied Sci. 2014;

6(4):233-40.

38. Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel

disease models in rodents. Korean J Physiol Pharmacol. 2014; 18(4):279-88.

39. Gulati P, Singh N. Evolving possible link between PI3K and NO pathways in neuroprotective

mechanism of ischemic postconditioning in mice. Mol Cell Biochem. 2014; 397(1-2):255-65.

40. Bhalla S, Singh N, Jaggi AS. Statins: do they aggravate or ameliorate neuropathic pain? Pain.

2014; 15(11):1069-80.

41. Neha, Sodhi RK, Jaggi AS, Singh N. Animal models of dementia and cognitive dysfunction. Life

Sci. 2014; 109(2):73-86

42. Mangat GS, Jaggi AS, Singh N. Ameliorative Effect of a Selective Endothelin ETA Receptor

Antagonist in Rat Model of L-Methionine-induced Vascular Dementia. Korean J Physiol

Pharmacol. 2014; 18(3):201-9.

43. Neha, Kumar A, Jaggi AS, Sodhi RK, Singh N. Silymarin ameliorates memory deficits and

neuropathological changes in mouse model of high-fat-diet-induced experimental dementia.

Naunyn Schmiedebergs Arch Pharmacol. 2014 ; 387(8):777-87.

44. Singh G, Sharma B, Jaggi AS, Singh N. Efficacy of bosentan, a dual ETA and ETB endothelin

receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and

associated dementia in rats. Pharmacol Biochem Behav. 2014; 124:27-35.

45. Gulati P, Singh N, Muthuraman A. Pharmacologic evidence for role of endothelial nitric oxide

synthase in neuroprotective mechanism of ischemic postconditioning in mice. J Surg Res. 2014;

188(1):349-60.

46. Kumar A, Jaggi AS, Singh N. Pharmacological investigations on possible role of Src kinases in

neuroprotective mechanism of ischemic postconditioning in mice. Int J Neurosci. 2014;

124(10):777-86.

47. Gupta S, Singh N, Jaggi AS. Alkaloids as aldose reductase inhibitors, with special reference to

berberine. J Altern Complement Med. 2014 Mar;20(3):195-205.

48. Gulati P, Singh N. Tadalafil enhances the neuroprotective effects of ischemic postconditioning in

mice, probably in a nitric oxide associated manner. Can J Physiol Pharmacol. 2014; 92(5):418-26.

49. Sodhi RK, Singh N. Liver X receptor agonist T0901317 reduces neuropathological changes and

improves memory in mouse models of experimental dementia. Eur J Pharmacol. 2014; 732:50-9.

50. Gulati P, Singh N. Neuroprotective mechanism of ischemic postconditioning in mice: a possible

relationship between protein kinase C and nitric oxide pathways. J Surg Res. 2014; 189(1):174-83.

51. Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic

complications. Korean J Physiol Pharmacol. 2014; 18(1):1-14.

52. Bali A, Singh N, Jaggi AS. Neuropeptides as therapeutic targets to combat stress-associated

behavioral and neuroendocrinological effects. CNS Neurol Disord Drug Targets. 2014; 13(2):347-

68.

53. Sodhi RK, Singh N. Retinoids as potential targets for Alzheimer's disease. Pharmacol Biochem

Behav. 2014; 120:117-23.

54. Verma V, Singh N, Singh Jaggi A. Pregabalin in neuropathic pain: evidences and possible

mechanisms. Curr Neuropharmacol. 2014; 12(1):44-56.

55. Jain V, Pareek A, Bhardwaj YR, Singh N. Attenuating effect of standardized fruit extract of

Punica granatum L in rat model of tibial and sural nerve transection induced neuropathic pain.

BMC Complement Altern Med. 2013; 13:274.

56. Bindra CS, Jaggi AS, Singh N. Role of P2X7 purinoceptors in neuroprotective mechanism of

ischemic postconditioning in mice. Mol Cell Biochem. 2014; 390(1-2):161-73.

57. Grewal AK, Jaggi AS, Rana AC, Singh N. Effect of neurosteroid modulation on global ischaemia-

reperfusion-induced cerebral injury in mice. Korean J Physiol Pharmacol. 2013 Dec;17(6):485-

91.

58. Verma V, Singh N, Jaggi AS. Sodium-hydrogen exchanger inhibitory potential of Malus

domestica, Musa×paradisiaca, Daucus carota, and Symphytum officinale. J Basic Clin Physiol

Pharmacol. 2013 Nov 2:1-10.

59. Gupta S, Singh N, Jaggi AS. Evaluation of in vitro aldose reductase inhibitory potential of

alkaloidal fractions of Piper nigrum, Murraya koenigii, Argemone mexicana, and Nelumbo

nucifera. J Basic Clin Physiol Pharmacol. 2013; 14:1-11.

60. Rehni AK, Jaggi AS, Singh N. Opioid withdrawal syndrome: emerging concepts and novel

therapeutic targets. CNS Neurol Disord Drug Targets. 2013; 12(1):112-125. (Impact Factor 3.81)

61. Muthuraman A, Singh N, Jaggi AS, Ramesh M. Drug Therapy of Neuropathic Pain: Current

Developments and Future Perspectives. Current drug targets 10/2013; (Impact Factor 3.93)

62. Singh VP, Singh N, Jaggi AS. A review on renal toxicity profile of common abusive drugs.

Korean Journal of Physiology and Pharmacology 2013; 17(4):347-57. (Impact Factor 0.96)

63. Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in

neuropathic pain. Arch Pharm Res. 2013; 36(3):237-251. (Impact Factor 1.54)

64. Sodhi RK, Singh N. Liver X receptors: emerging therapeutic targets for Alzheimer's disease.

Pharmacol Res. 2013; 72:45-51. (Impact Factor 4.41)

65. Kant R, Bali A, Singh N, Jaggi AS. Prolyl 4 hydroxylase: a critical target in the pathophysiology

of diseases. Korean J Physiol Pharmacol. 2013; 17(2):111-120. (Impact Factor 0.96)

66. Jain V, Pareek A, Paliwal N, Ratan Y, Jaggi AS, Singh N. Antinociceptive and antiallodynic

effects of Momordica charantia L. in tibial and sural nerve transection-induced neuropathic pain in

rats. Nutr Neurosci. 2013. [Epub ahead of print] (Impact Factor 1.65)

67. Bali A, Gupta S, Singh N, Singh Jaggi A. Implicating the role of plasma membrane localized

calcium channels and exchangers in stress-induced deleterious effects. Eur J Pharmacol. 2013;

15;714(1-3):229-238. (Impact Factor 2.78)

68. Kukkar A, Singh N, Jaggi AS. Attenuation of neuropathic pain by sodium butyrate in an

experimental model of chronic constriction injury in rats.J Formos Med Assoc. 2013. [Epub ahead

of print] (Impact Factor 1.13)

69. Sodhi RK, Singh N. Defensive Effect of Lansoprazole in Dementia of AD Type in Mice Exposed

to Streptozotocin and Cholesterol Enriched Diet. PLoS One, 2013;31;8(7):e70487. (Impact Factor

4.09)

70. Gulati P, Singh N. Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-

NAME in mouse model of ischemia-reperfusion injury. J Surg Res, 2013 [Epub ahead of print].

(Impact Factor 2.12)

71. Kukkar A, Singh N, Jaggi AS. Neuropathic pain-attenuating potential of aliskiren in chronic

constriction injury model in rats. J Renin Angiotensin Aldosterone Syst. 2013; 14(2):116-123.


72. Gulati P, Muthuraman A, Jaggi AS, Singh N. Neuroprotective effect of gadolinium: a stretch-

activated calcium channel blocker in mouse model of ischemia-reperfusion injury. Naunyn-

Schmiedeberg's archives of pharmacology. 2013; 386(3):255-264 (Impact Factor 2.147)

73. Sharma B, Singh N. Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and

nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and

biochemistry of hypertension induced vascular dementia in rats. Pharmacol Biochem Behav. 2013;

103(4):821-830. (Impact Factor 2.97)

74. Singh B, Sharma B, Jaggi AS, Singh N. Attenuating effect of lisinopril and telmisartan in

intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type:

possible involvement of PPAR-γ agonistic property. J Renin Angiotensin Aldosterone Syst. 2013;

14(2):124-136. (Impact Factor 2.44)

75. Sodhi RK, Singh N. All-trans retinoic acid rescues memory deficits and neuropathological

changes in mouse model of streptozotocin-induced dementia of Alzheimer's type. Prog

Neuropsychopharmacol Biol Psychiatry. 2013; 40C:38-46. (Impact Factor 2.82)

76. Thiagarajan VR, Shanmugam P, Krishnan UM, Muthuraman A, Singh N. Ameliorative potential

of Butea monosperma on chronic constriction injury of sciatic nerve induced neuropathic pain in

rats.An Acad Bras Cienc. 2012; 84(4):1091-1104. (Impact Factor 1.09)

77. Bali A, Singh N, Jaggi AS. Investigations into mild electric foot shock stress-induced cognitive

enhancement: possible role of angiotensin neuropeptides. J Renin Angiotensin Aldosterone Syst.

2013; 14(3):197-203. (Impact Factor 0.85)

78. Muthuraman A, Singh N. Neuroprotective effect of saponin rich extract of Acorus calamus L. in

rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. J

Ethnopharmacol. 2012; 142(3):723-731. (Impact Factor 2.32)

79. Rinwa P, Jaggi AS, Singh N. Pharmacological investigation of memory restorative effect of

riluzole in mice. Indian J Pharmacol. 2012; 44(3):366-371. (Impact Factor 0.27)

80. Singh AP, Junemann A, Muthuraman A, Jaggi AS, Singh N, Grover K, Dhawan R. Animal

models of acute renal failure. Pharmacol Rep. 2012; 64(1):31-44. (Impact Factor 2.45)

81. Anand P, Singh B, Jaggi AS, Singh N. Mast cells: an expanding pathophysiological role from

allergy to other disorders. Naunyn Schmiedebergs Arch Pharmacol. 2012; 385(7):657-670.


82. Sharma B, Singh N. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and

lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology

(Berl). 2012; 223(3):307-317. (Impact Factor 4.11)

83. Sharma B, Singh N. Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-

hyperlipidemia induced vascular dementia. Prog Neuropsychopharmacol Biol Psychiatry. 2012

38(2):207-215. (Impact Factor 2.82)

84. Sharma B, Singh N. Experimental hypertension induced vascular dementia: pharmacological,

biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase

inhibitor. Pharmacol Biochem Behav. 2012; 102(1):101-108. (Impact Factor 2.97)

85. Rehni AK, Singh N. Potential involvement of tyrosine phosphatase and calpain-related pathways

in opioid withdrawal syndrome in mice. Behav Pharmacol. 2012; 23(3):302-309. (Impact Factor

2.85)

86. Jaggi AS, Singh N. Intrathecal delivery of farnesyl thiosalicylic acid and GW 5074 attenuates

hyperalgesia and allodynia in chronic constriction injury-induced neuropathic pain in rats. Neurol

Sci. 2013; 34(3):297-304. (Impact Factor 1.12)

87. Rehni AK, Singh N, Rachamalla M, Tikoo K. Modulation of histone deacetylase attenuates

naloxone-precipitated opioid withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol.

2012; 385(6):605-619. (Impact Factor 2.63)

88. Jaggi AS, Singh N. Analgesic potential of intrathecal farnesyl thiosalicylic acid and GW 5074 in

vincristine-induced neuropathic pain in rats. Food Chem Toxicol. 2012; 50(5):1295-1301. (Impact

Factor 2.11)

89. Thiagarajan VR, Shanmugam P, Krishnan UM, Muthuraman A, Singh N. Antinociceptive effect

of Butea monosperma on vincristine-induced neuropathic pain model in rats. Toxicol Ind Health.

2013;29(1):3-13. (Impact Factor 0.91)

90. Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for

Alzheimer's disease. Bioorg Med Chem. 2012; 20(3):1175-1180. (Impact Factor 2.82)

91. Kumar N, Singh N, Jaggi AS. Anti-stress effects of cilnidipine and nimodipine in immobilization

subjected mice. Physiol Behav. 2012; 105(5):1148-1155. (Impact Factor 3.30)

92. Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral

neuropathy. Toxicology. 2012; 291(1-3):1-9. (Impact Factor 3.24)

93. Singh AP, Singh AJ, Singh N. Pharmacological investigations of Punica granatum in glycerol-

induced acute renal failure in rats. Indian J Pharmacol. 2011; 43(5):551-556. (Impact Factor 0.27)

94. Rehni AK, Singh N. Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid

withdrawal in vivo and in vitro. Psychopharmacology (Berl). 2012; 220(2):427-438. (Impact

Factor 4.10)

95. Jaggi AS, Bhatia N, Kumar N, Singh N, Anand P, Dhawan R. A review on animal models for

screening potential anti-stress agents. Neurol Sci. 2011; 32(6):993-1005. (Impact Factor 1.12)

96. Sharma B, Singh N. Behavioral and biochemical investigations to explore pharmacological

potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem

Behav. 2011; 100(2):320-329. (Impact Factor 2.97)

97. Muthuraman A, Singh N, Jaggi AS. Protective effect of Acorus calamus L. in rat model of

vincristine induced painful neuropathy: an evidence of anti-inflammatory and anti-oxidative

activity. Food Chem Toxicol. 2011; 49(10):2557-2563. (Impact Factor 2.11)

98. Jaggi AS, Singh N. Exploring the potential of telmisartan in chronic constriction injury-induced

neuropathic pain in rats. Eur J Pharmacol. 2011; 667(1-3):215-221. (Impact Factor 2.59)

99. Jaggi AS, Singh N. Therapeutic targets for the management of peripheral nerve injury-induced

neuropathic pain. CNS Neurol Disord Drug Targets. 2011; 10(5):589-609. (Impact Factor 3.57)

100. Sodhi RK, Singh N, Jaggi AS. Neuroprotective mechanisms of peroxisome proliferator-

activated receptor agonists in Alzheimer's disease. Naunyn Schmiedebergs Arch Pharmacol. 2011;

384(2):115-124. (Impact Factor 2.65)

101. Bhatia N, Jaggi AS, Singh N, Anand P, Dhawan R. Adaptogenic potential of curcumin in

experimental chronic stress and chronic unpredictable stress-induced memory deficits and

alterations in functional homeostasis. J Nat Med. 2011; 65(3-4):532-543. (Impact Factor 1.03)

102. Manchanda RK, Jaggi AS, Singh N.Ameliorative potential of sodium cromoglycate and

diethyldithiocarbamic acid in restraint stress-induced behavioral alterations in rats. Pharmacol

Rep. 2011; 63(1):54-63. (Impact Factor 2.21)

103. Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic

constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-

inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med.

2011; 11(1):24. (Impact Factor 2.24)

104. Muthuraman A, Singh N. Attenuating effect of hydroalcoholic extract of Acorus calamus

in vincristine-induced painful neuropathy in rats. J Nat Med. 2011; 65(3-4):480-487. (Impact

Factor 1.03)

105. Sauriyal DS, Jaggi AS, Singh N, Muthuraman A. Investigating the role of endogenous

opioids and K(ATP) channels in glycerol-induced acute renal failure. Fundam Clin Pharmacol.

2012; 26(3):347-355. (Impact Factor 2.372)

106. Agrawal A, Jaggi AS, Singh N. Pharmacological investigations on adaptation in rats

subjected to cold water immersion stress. Physiol Behav. 2011; 103(3-4):321-329. (Impact Factor

3.30)

107. Sharma B, Singh N. Attenuation of vascular dementia by sodium butyrate in

streptozotocin diabetic rats. Psychopharmacology (Berl). 2011; 215(4):677-687. (Impact Factor

4.10)

108. Rehni AK, Singh N. Modulation of src-kinase attenuates naloxone-precipitated opioid

withdrawal syndrome in mice. Behav Pharmacol. 2011; 22(2):182-190. (Impact Factor 2.85)

109. Jaggi AS, Singh N. Role of different brain areas in peripheral nerve injury-induced

neuropathic pain. Brain Res. 2011; 1381:187-201. (Impact Factor 2.46)

110. Jain V, Jaggi AS, Singh N. Non-beneficial effects of rosiglitazone in oxaliplatin-induced

cold hyperalgesia in rats. J Pharmaceutical Negative Results. 2011; 2:28-34. . (Impact Factor

0.454)

111. Jaggi AS, Jain V, Singh N. Animal models of neuropathic pain. Fundam Clin Pharmacol.

2011; 25(1):1-28. (Impact Factor 2.37).

112. Sauriyal DS, Jaggi AS, Singh N. Extending pharmacological spectrum of opioids beyond

analgesia: Multifunctional aspects in different pathophysiological states. Neuropeptides. 2011;

45(3):175-88. (Impact Factor 2.04).

113. Muthuraman A, Singh N, Jaggi AS.Effect of hydroalcoholic extract of Acorus calamus on

tibial and sural nerve transection-induced painful neuropathy in rats. J Nat Med. 2011; 65(2):282-

292. (Impact Factor 1.03)

114. Dalla Y, Singh N, Jaggi AS, Singh D. Memory restorative role of statins in experimental

dementia: an evidence of their cholesterol dependent and independent actions. Pharmacol Rep

2010; 62(5):784-796 (Impact Factor 2.21)

115. Saklani R, Jaggi A, Singh N. Pharmacological Preconditioning by Milrinone: Memory

Preserving and Neuroprotective Effect in Ischemia-Reperfusion Injury in Mice. Arch Pharm Res.

2010; 33(7):1049-1057 (Impact Factor 1.59)

116. Sharma D, Puri M, Tiwary AK, Singh N, Jaggi AS. Anti-amnesic Effect of Stevioside in

Scopolamine Treated Rats. Indian J Pharmacol. 2010; 42: 164-167. (Impact Factor 0.27).

117. Kumar R, Jaggi AS, Singh N. Effects of erythropoietin on memory deficits and brain

oxidative stress in the mouse models of dementia. Korean J Physiol Pharmacol. 2010; 14(5):345-

352.

118. Sharma B, Singh N. Pitavastatin and 4'-Hydroxy-3'-methoxyacetophenone (HMAP)

Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes. Curr

Neurovasc Res. 2010; 7(3):180-191(Impact Factor 3. 23).

119. Sodhi RK, Singh N, Jaggi AS. Poly (ADP-ribose) polymerase-1 (PARP-1) and its

therapeutic implications. Vascul Pharmacol. 2010; 53(3-4):77-87 (Impact Factor 2.1)

120. Kaur G, Jaggi AS, Singh N. Ameliorative potential of pralidoxime in tibial and sural nerve

transection-induced neuropathic pain in rats. Biol Pharm Bull. 2010; 33(8):1331-1336. (Impact

Factor 1.81)

121. Jaggi AS, Singh N. Differential Effect of Spironolactone in Chronic Constriction Injury

and Vincristine-Induced Neuropathic Pain in Rats. European J Pharmacol 2010; 648(1-3):102-


122. Rinwa P, Kaur B, Jaggi AS, Singh N. Involvement of PPAR-gamma in curcumin-

mediated beneficial effects in experimental dementia. Naunyn Schmiedebergs Arch Pharmacol.

2010; 381(6):529-539 (Impact Factor 2.63)

123. Kaur G, Jaggi AS, Singh N. Exploring the potential effect of Ocimum sanctum in

vincristine-induced neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj. 2010; 5: 3.

124. Pal Singh A, Kaur T, Dahiya RS, Singh N, Singh Bedi PM. Ameliorative Role of

Rosiglitazone in Hyperhomocysteinemia-Induced Experimental Cardiac Hypertrophy. J

Cardiovasc Pharmacol. 2010; 56(1):53-59 (Impact Factor 2.83)

125. Kaur H, Jaggi AS, Singh N. Modulation of neuroprotective effect of ischemic

postconditioning by dichlorbenzamil a Na + / Ca ++ exchanger inhibitor in mice. Biol Pharm Bull,

2010; 33 (4): 585-591. (Impact Factor 1.81)

126. Rehni AK, Singh TG, Bhateja P, Singh N, Arora S. Involvement of cyclic adenosine

diphosphoribose receptor activation in ischemic preconditioning induced protection in mouse

brain. Brain Res. 2010; 1309: 75-82. (Impact Factor 2.46)

127. Rehni AK, Singh TG, Singh N, Arora S. Tramadol-induced seizurogenic effect: a possible

role of opioid-dependent histamine (H1) receptor activation-linked mechanism. Naunyn

Schmiedebergs Arch Pharmacol. 2010; 381(1): 11-19. (Impact Factor 2.63)

128. Kaur R, Jaggi AS, Singh N. Studies on effect of stress preconditioning in restrain stress-

induced behavioral alterations. Yakugaku Zasshi. 2010; 130(2): 215-221 (Impact Factor 0.39)

129. Dalla Y, Singh N, Jaggi AS, Singh D, Ghulati P. Potential of ezetimibe in memory deficits

associated with dementia of Alzheimer’s type in mice. Indian J Pharmacol, 2009; 41: 262-267.

(Impact Factor 0.27).

130. Rehni AK, Singh N. Reversal of pentylenetetrazole-induced seizure activity in mice by

nickel chloride. Indian J Pharmacol. 2009; 41(1): 15-8. (Impact Factor 0.27).

131. Jain V, Singh N, Jaggi AS, Singh D. Ameliorative potential of rosiglitazone in tibial and

sural nerve transection induced painful neuropathy in rats. Pharmacol Res. 2009; 59(6): 385-92.


132. Rehni AK, Singh TG, Kalra R, Singh N. Pharmacological inhibition of inducible nitric

oxide synthase attenuates the development of seizures in mice. Nitric Oxide. 2009; 21(2): 120-


133. Sodhi RK, Singh M, Singh N, Jaggi AS. Protective effects of caspase-9 and poly (ADP-

ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury. Arch Pharm

Res. 2009 Jul; 32(7): 1037-1043. (Impact Factor 1.59).

134. Kaur B, Singh N, Jaggi AS.Exploring mechanism of pioglitazone-induced memory

restorative effect in experimental dementia. Fundam Clin Pharmacol. 2009; 23(5): 557-66.


135. Kaur S, Jaggi AS, Singh N. Molecular aspects of ischaemic postconditioning. Fundam

Clin Pharmacol. 2009; 23(5): 521-536 (Impact Factor 2.37)

136. Khan N, Bakshi KS, Jaggi AS, Singh N. Ameliorative potential of spironolactone in

diabetes induced hyperalgesia in mice. YakuGakuZasshi 2009; 129(5):593-9. (Impact Factor

0.386)

137. Kaur S, Rehni AK, Singh N, Jaggi AS. Studies on cerebral protection of digoxin against

ischemia/reperfusion injury in mice. YakuGaku Zasshi. 2009; 129(4): 435-443. (Impact Factor

0.39)

138. Koladiya RU, Jaggi AS, Singh N, Sharma BK. Beneficial effects of donepezil on vascular

endothelial dysfunction-associated dementia induced by L-methionine in rats. J. Health Sci., 2009;

55(2): 215-225. (Impact Factor0.754)

139. Rehni AK, Bhateja P, Singh N. Diethyl dithiocarbamic acid, a possible nuclear factor

kappa B inhibitor, attenuates ischemic postconditioning-induced attenuation of cerebral ischemia-

reperfusion injury in mice. Can J Physiol Pharmacol. 2009; 87(1): 63-68. (Impact Factor 1.95)

140. Singh K, Jaggi AS, Singh N. Exploring the ameliorative potential of Punica granatum in

dextran sulphate sodium induced ulcerative colitis in mice. Phytother Res. 2009; 11: 1565-1574.


141. Diwan V , Jaggi A S, Singh M, Singh N, Singh D. Possible Involvement of Erythropoietin

in Remote Renal Preconditioning Induced Cardioprotection in Rats. J Cardiovas Pharmacol,

(2008); 51(2): 126-130. (Impact Factor 2.29)

142. Rehni AK, Singh I, Singh N, Bansal N, Bansal S, Kumar M. Pharmacological modulation

of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of

naloxone-induced opioid withdrawal syndrome. Eur J Pharmacol. 2008; 598 (1-3): 51-56. (Impact

Factor 2.52)

143. Kaur K, Singh M, Singh N, Jaggi AS. Possible Mechanism of Rottlerin Induced

modulation of Ischemia Reperfusion Injury in Isolated Rat Hearts. Biol Pharm Bull., 2008; 31 (9):

1745-8. (Impact Factor 1.66)

144. Pateliya BB, Singh N, Jaggi AS. Possible Role of Opioids and KATP Channels in

Neuroprotective Effect of Postconditioning in Mice. Biol Pharm Bull., 2008: 31 (9): 1755-60.


145. Koladiya RU, Jaggi AS, Singh N, Sharma BK. Ameliorative Role of Atorvastatin and

Pitavastatin in L-Methionine Induced Vascular Dementia in Rats. BMC Pharmacol 2008; 8:14.

146. Sharma B, Singh N, Singh M. Modulation of celecoxib- and streptozotocin-induced

experimental dementia of Alzheimer's disease type by pitavastatin and donepezil. J

Psychopharmacol. 2008; 22(2):162-171. (Impact Factor 3.04)

147. Sharma B, Singh N, Singh M and Jaggi AS. Exploitation of HIV protease inhibitor

Indinavir as a memory restorative agent in experimental dementia. Pharmacol Biochem Behav

2008; 89(4): 535-545. (Impact Factor 2.53)

148. Khanna G, Diwan V, Singh M, Singh N, Jaggi AS. Reduction of ischemic,

pharmacological and remote preconditioning effects by an antioxidant N acetyl cysteine

pretreatment in isolated rat heart. YakuGaku Zasshi, 2008; 128(3): 469-477. (Impact Factor 0.39)

149. Kant R, Diwan V, Jaggi AS, Singh N, Singh D. Remote renal preconditioning-induced

cardioprotection: a key role of hypoxia inducible factor-prolyl 4-hydroxylases. Mol Cell Biochem.

2008; 312: 25-31. (Impact Factor 2.06)

150. Diwan V, Kant R, Jaggi AS, Singh N, Singh D. Signal mechanism activated by

erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection. Mol

Cell Biochem. 2008; 315:195–201. (Impact Factor 2.06)

151. Rehni AK, Singh TG, Singh N, Jaggi AS. Pharmacological preconditioning of brain: A

possible interplay between opioid and CGRP transduction systems. Pharmacol Rep 2008; 60:

904–913. (Impact Factor 2.167)

152. Muthuraman A, Jaggi AS, Singh N, Singh D. Ameliorative effects of amiloride and

pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats. Eur J

Pharmacol. 2008; 587(1-3): 104-11. (Impact Factor 2.52)

153. Rehni AK, Singh I, Singh N, Kumar M. Stem Cells: Implications in experimental

ischaemic stroke therapy. Stem Cell Rev. 2008; 4(3): 227-33. (Impact Factor 3.74)

154. Khan N, Singh N, Jaggi AS. Possible Role of Spleen Derived Factors, Vanilloid Receptors

and CGRP in Diabetes induced Hyperalgesia in Mice. YakuGakuZasshi2008; 128(11):1699-705.


155. Muthuraman A, Diwan V, Jaggi AS, Singh N, Singh D. Ameliorative Effects of Ocimum

sanctum in Sciatic Nerve Transection Induced Neuropathy in Rats. J Ethnopharmacol. 2008;

120(1): 56-62. (Impact Factor 3.01)

156. Rehni AK, Bhateja P, Singh TG, Singh N. Nuclear factor-kappa-B inhibitor modulates the

development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal

syndrome. Behav Pharmacol. 2008; 19(3): 265-269. (Impact Factor 2.72)

157. Rehni AK, Bhateja P, Singh N, Jaggi AS. Implication of mast cell degranulation in

ischemic preconditioning-induced prevention of cerebral injury. Fundam Clin Pharmacol. 2008;

22(2): 179-188. (Impact Factor 2.37)

158. Rehni AK, Singh N, Jindal S. Sodium Orthovanadate Treatment Reverses Protracted

Methionine Administration Induced Schizophrenia Like Behavior in Rats. Iranian J Pharmacol

Ther, 2007; 6(1)

159. Rehni A K, Singh N, Jaggi A S. Possible involvement of Insulin, Endogenous Opioids,

and Calcitonin gene related peptide in Remote Ischaemic preconditioning of Brain. YakuGaku

Zasshi 2007; 127 (6): 1013-1020. (Impact Factor 0.39)

160. Rehni A K, Singh N, Jaggi A S, Singh M. Amniotic fluid derived stem cells ameliorate focal

cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res 2007;

183, 95-100. (Impact Factor 3.42)

161. Jaggi A S, Singh M, Sharma A, Singh D, Singh N. Cardioprotective Effects of Mast cell

Modulators in Ischaemia–Reperfusion- Induced Injury in Rats. Meth Find Exp Clin Pharmacol,

2007; 29 (9): 593-600. (Impact Factor 0.454)

162. Rehni AK, Singh N, Jindal S. Role of ATP-sensitive potassium channels in the piracetam induced

blockade of opioid effects. Indian J Exp Biol. 2007; 45(12): 1050-1054. (Impact Factor 1.30)

163. Parle M, Singh N. Reversal of memory deficits by Atorvastatin and Simvastatin in rats. Yakugaku

Zasshi. 2007; 127(7): 1125-1137. (Impact Factor 0.39)

164. Rehni AK, Singh N. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced

attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep. 2007; 59(2):


165. Prakash A, Singh N, Singh M. Beneficial effects of statins on experimental amnesia. Iranian J

Pharmacol Ther 2007; 6:125-132.

166. Parle M, Singh N, Vasudevan M. Regular rehearsal helps in consolidation of long term memory.

J Sport Sci Med 2006; 5: 80 – 88. (Impact Factor 0.564).

167. Parle, M., Vasudevan M, Singh N. Swim everyday to keep dementia away. J Sport Sci Med 2005;

4: 37-46. (Impact Factor 0.564)

168. Parle M, Singh N. Animal models for testing memory. Asia Pacific Journal of Pharmacology

2004; 16: 101-120.

169. Singh N, Parle M. Sildenafil improves acquisition and retention of memory in mice. Indian J

Physiol Pharmacol. 2003; 47(3): 318-24.

170. Singh N, Sharma A, Singh M. Possible mechanism of alprazolam-induced amnesia in mice.

Pharmacology. 1998; 56(1): 46-50. (Impact Factor 1.833)

171. Singh N, Sharma A, Singh M. Effects of BN-50730 (PAF receptor antagonist) and physostigmine

(AChE inhibitor) on learning and memory in mice. Methods Find Exp Clin Pharmacol. 1997; 19(9):


Books/ Book chapter:

1. Rehni AK, Singh N. Stem cells: Ischaemic stroke therapy, Eds. Singh SR, Mishra PK, Hou SX.

In: Stem Cells: Organogenesis and Cancer. Transworld Research Network, Trivandrum, India.

(2010), ISBN: 978-81-7895-487-5.

2. Singh N, Sharbai S. Exploring mechanism of Erythropoietin mediated benefits in dementia. Lambert Publishing House, Germany (2014), ISBN 378-3-659-55386-8

3. Jaggi AS, Bali Anjana, Singh N. Viva Voce in Experimental Pharmacology. CBC Publishers & Distributors, New Delhi, India (2014), ISBN: 978-81-239-2520-2.

4. Singh N, Gill J. Jaggi AS. K-Channels In Cerebroprotective Mechanism Of Ischemic Postconditioning. Lambert Publishing House, Germany (2015), ISBN 978-3-659-68279-7

5. Neha, Jaggi AS, Singh N. Silymarin and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016; 929:25-44 (Book Chapter). 6. Rehni AK, Singh I, Singh N, Kumar M. Stem cells: implications in experimental ischaemic stroke therapy. Stem Cell Rev. 2008 Sep;4(3):227-33 (Book Chapter)..

Date: 30/10/ 2017 Nirmal Singh

dr nirmal latest biodata - punjabi university&kdxkdq ( %dol $ 6lqjk 1 -djjl $6 &urvv vwuhvv...

Documents